Company profile: Mortara
1.1 - Company Overview
Company description
- Provider of electrocardiography (ECG) products designed to meet clinical needs with simplicity and economic accessibility, delivering value without performance compromise for today's healthcare market.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Mortara
Phraxis
HQ: United States
Website
- Description: Provider of medical devices enabling vascular access for hemodialysis, including EndoForce, a transcatheter-delivered endovascular anastomotic connector designed for coaxial anastomosis of a vein to an arteriovenous graft, featuring a flexible nitinol segment, a rigid segment for radial force, and nitinol anchoring barbs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phraxis company profile →
Bellerophon Therapeutics
HQ: United States
Website
- Description: Provider of innovative products that combine novel drugs and devices for the treatment of cardiopulmonary diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bellerophon Therapeutics company profile →
InspireMD
HQ: United States
Website
- Description: Provider of medical device solutions focused on proprietary stent system technology (MGuard), including CGuard EPS, a carotid stent using MicroNet mesh to trap and seal thrombus and plaque to help prevent stroke, and SwitchGuard NPS, a neuroprotection system intended for Transcarotid Artery Revascularization (TCAR) procedures, currently under clinical trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InspireMD company profile →
BTG
HQ: United Kingdom
Website
- Description: Provider of interventional medicine, pharmaceuticals, and licensing solutions, acquiring, developing, manufacturing, and commercializing products globally. Interventional oncology offerings include beads and TheraSphere Y-90 Glass Microspheres for HCC; other devices include Jetstream Atherectomy System, Vercise Genus DBS, Varithena 1% foam, WaveWriter Alpha SCS, and AcuPulse DUO CO2 Laser.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BTG company profile →
Vantis Vascular
HQ: United States
Website
- Description: Provider of vascular intervention technology for complex arteries, offering the DuoPRO™ system to navigate tortuous, calcific, and stented arteries and deliver therapeutic devices to distal coronary or peripheral anatomies. Features include the Seamless Profile low-profile tapered design, an inner microcatheter with pushability and atraumatic tip, and an outer delivery catheter enabling smooth navigation and delivery to distal lesions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vantis Vascular company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Mortara
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Mortara
2.2 - Growth funds investing in similar companies to Mortara
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Mortara
4.2 - Public trading comparable groups for Mortara
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →